Skip to main content
Medical information Clinical review pending

Infection Testing

BAS Congo Virus RNA Detection Qualitative Test

Detects the presence of Congo Virus RNA using Real Time PCR technology. Essential for diagnosing viral infections, especially in symptomatic individuals or those with known exposure.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Whole blood, serum, plasma, or cerebrospinal fluid (CSF). Confirm specific requirements with the laboratory before booking.
Results
Results are typically available within 48 hours via email and 36 hours by phone. Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. However, inform the laboratory about any medications you are taking.
Test priceKSh 19,040

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the BAS Congo Virus RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms suggestive of viral infection (e.g., fever, fatigue)
  • ✓Known or suspected exposure to Congo Virus
  • ✓Monitoring for infection in high-risk individuals
  • ✓Diagnostic confirmation in suspected cases
02

In plain language

What this test helps you understand

This test is used to confirm or rule out an active Congo Virus infection by detecting the virus's genetic material (RNA). It aids in the diagnosis of viral infections, particularly in patients presenting with relevant symptoms or exposure history.
The BAS Congo Virus RNA Detection Qualitative Test is a diagnostic tool used to identify the presence of the Congo Virus in patients. This test uses the Real Time PCR method to detect viral RNA in samples like whole blood, serum, plasma, and cerebrospinal fluid (CSF). Early detection is important for managing viral infections.

This test specifically measures and detects the RNA of the Congo Virus. Knowing if the virus is present helps healthcare providers make timely decisions about treatment and management.

Individuals showing symptoms of viral infections, such as fever or fatigue, should consider this test. People with known exposure to the Congo Virus or those at risk due to their work or environment may also benefit from this testing.

Benefits of this test include early detection, which allows for prompt medical care, monitoring treatment effectiveness, and providing reassurance regarding health concerns. Convenient testing options, including home sample collection, are available.

Results are typically available within 48 hours via email and 36 hours by phone. A positive result indicates the virus is present, while a negative result means no viral RNA was detected. Discuss your results with a healthcare provider for proper interpretation.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. However, inform the laboratory about any medications you are taking.
SampleWhole blood, serum, plasma, or cerebrospinal fluid (CSF). Confirm specific requirements with the laboratory before booking.
MethodologyReal Time PCR (Polymerase Chain Reaction).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the presence of viral RNA but does not quantify the viral load. A negative result does not completely rule out infection, especially if the sample was collected very early or late in the infection. False negatives or positives can occur, though rare. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects the genetic material (RNA) of the Congo Virus.
Samples can be whole blood, serum, plasma, or cerebrospinal fluid (CSF). Home sample collection may be available.
Results are typically available within 48 hours via email and 36 hours by phone.
A positive result indicates that the Congo Virus RNA was detected in the sample.
No special preparation is usually required for this test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp